Abstract
Rationale:
Pulmonary inflammatory myofibroblastic tumor (IMT) is a rare borderline tumor, which has the potential of malignant including invasion of surrounding tissues, distant metastasis and recurrence. However, the preoperative diagnosis is difficult and it can also be difficult to distinguish from malignancy in small tissue samples. Preoperative accurate diagnosis has important clinical significance for patients to choose treatment measures and improve the quality of rehabilitation. We was examined by computed tomography (CT) plain scan plus enhanced scan, magnetic resonance diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) imaging technology in an adult female, compared with lung cancer and pulmonary cryptococcus infection for diagnosis of pulmonary IMT.
Patient concerns:
A 32-year-old female patient was admitted to the hospital “physical examination revealed nodules in the right upper lung for 1 week”.
Diagnoses:
The patient was diagnosed with Pulmonary inflammatory myofibroblastic tumor.
Interventions:
Single-port thoracoscopic lobectomy was performed after multidisciplinary consultation.
Outcomes:
DWI and ADC improves the accuracy of preoperative diagnosis and well guides the formulation of treatment measures. The combined CT, DWI, and ADC magnetic resonance imaging technology has more important significance in the diagnosis and differential diagnosis of IMT and lung malignant tumors.
Lessons:
Although accurate preoperative diagnosis of pulmonary IMT is difficult. Chest CT examination combined with DWI and ADC imaging technology has high clinical significance for the diagnosis of IMT.
Keywords: pulmonary nodules, inflammatory myofibroblastic tumor, imaging diagnosis, case report
1. Introduction
The increase of health examination and the improvement of medical technology make the detection rate of pulmonary masses increase dramatically. The growth, evolution, nature and size of the masses determine the different of treatment methods. Benign pulmonary nodules can be treated conservatively, while malignant tumors need the combination of multiple treatment methods, mainly surgery. An expert consensus agreed that it is of great significance for the diagnosis and treatment of related diseases and the long-term health of patients, especially during the COVID-19 pandemic.[1]
Inflammatory myofibroblastic tumor (IMT) is a kind of soft tissue tumor that commonly occurs in children and young adults. “The WHO Classification of Soft Tissue and Bone Tumors,” prepared by the WHO Editorial Board of Cancer in 2020, classified IMT as an intermediate (occasionally metastatic) tumor.[2] The lung, omentum, mesentery and other soft tissues are the most common sites of IMT, among which the lung accounts for about 1/3, most of which show local invasive growth, and about 5% of the total IMT may show distant metastasis.[3,4] Surgical resection is the main treatment for tumors in situ, while targeted therapy is more relied on for distant metastasis and recurrent tumors.[5] Since the overall incidence of pulmonary IMT is low and difficult to diagnose, Multidisciplinary imaging examination can provide effective diagnostic basis, which can provide effective guidance for the selection of surgical treatment before metastasis of this disease, and helpful to improve the long-term health quality of patients.
2. Patient information
A 32-year-old female patient was admitted to the hospital “physical examination revealed nodules in the right upper lung for 1 week.” she did not show any symptoms or signs of respiratory disease in the past 3 months. No previous history of respiratory diseases such as recurrent wheezing, cough, expectoration, hemoptysis, infection, etc, and no person from a high-risk area of COVID-19.
3. Clinical findings
The thorax was symmetrical. There were no wet or dry rales on auscultation. Lung function tests were normal.
4. Timeline (Fig. 1)
5. Diagnostic assessment
Chest computed tomography (CT) in other hospital showed nodules in the upper lobe apex of the right lung, and sclerosing alveolar cell tumor and carcinoid were considered. Admission diagnosis: right upper lung mass. Chest CT examination was performed on the same day after admission (Fig. 2A–D), which showed soft tissue density nodules of about 23 × 16 × 19 mm3 in the right upper lung, with shallow lobulated edges and adjacent pleural traction depression, mild to moderate uneven enhancement on enhanced scanning, and small mediastinum and hilar lymph nodes. Imaging diagnosis: right upper lung nodules, inflammatory lesions are likely. To further determine the surgical plan, chest magnetic resonance imaging examination was performed the next day (Fig. 2E–H). The results showed T1 and slightly longer T2 signal nodules with a size of 23 × 16 × 19 mm3 in the right upper lung, with superficial lobulated edges, high intensity on diffusion-weighted imaging (DWI) and high intensity on apparent diffusion coefficient (ADC), adjacent pleural thickening, no enlargement of mediastinal and hilar lymph nodes, and a small amount of bilateral pleural effusion. Imaging diagnosis: Nodules in the right upper lung tend to be inflammatory lesions, and tumors were excluded by close follow-up; Bilateral small amount of pleural effusion. Blood test: WBC9.34 × 109/L, N 0.77%, L 0.12%.
6. Therapeutic intervention
The surgical plan was determined based on the opinions of the imaging department, the Department of pathology and the Department of anesthesiology. Single-port thoracoscopic lobectomy was performed (Fig. 3A). The operation process was smooth. After the operation, the endotracheal tube was removed and returned to the ward awake.
7. Follow-up and outcomes
Immunohistochemical results of postoperative paraffin sections showed a right upper pneumonic myofibroblastoma (Fig. 3B and C). The patient was discharged from hospital 1 week later. No special discomfort was observed during 8 months of follow-up.
8. Discussion
IMT is a rare tumor with systemic onset but unknown origin, especially occurring in the chest tissue, and the incidence of lung tumors is <1%.[6] IMT is an intermediate tumor with a tendency to develop into malignant tumors. Pulmonary IMT may occur at all ages, and patients may present with asymptomatic symptoms, chronic cough, hemoptysis, and progressive dyspnea according to the disease evolution, tumor size and location.[7–9] It is difficult to make a direct diagnosis before histopathological results are obtained. With the promotion of the development of multidisciplinary cooperation, it is of practical clinical significance to make a clear preoperative diagnosis for the choice of surgical methods, improve the treatment effect, and promote rapid recovery for such patients.
Imaging combined with tissue puncture and pathological examination is an effective method to determine the nature of lung masses, but this method has risks and disadvantages such as small sample size, vascular injury, and tumor metastasis.[10] In clinical practice, it is more common to rely solely on imaging to preliminarily define the nature of the mass and make diagnosis and treatment plans. In many imaging reports of IMT of the lung, CT examination results are almost all used, which usually suggest solitary nodules in the lung, with different shapes and usually no lymphadenopathy. Enhanced scanning is mainly characterized by different degrees of delayed enhancement,[9,11,12] which is similar to the CT findings of this case. For now, MR manifestation of pulmonary inflammatory muscle fibroblastoma is given priority to with case reported, the patients were MR performance for T1 is a bit long T2 signals, such as no necrosis internal signals, do not agree with Naime reports,[13] consideration may be related to this study small nodules, has not yet occurred necrosis and inflammatory muscle fibroblastoma image performance related diversification. Magnetic resonance DWI and ADC are of great significance for the differentiation of benign and malignant tumor lesions in multiple organs of the body, including the lung,[14–17] and the ADC value of benign lung lesions is higher than that of malignant lung lesions.[18] In this patient with IMT, DWI, and ADC sequence examination were added before operation, and the results showed that both DWI and ADC of the right upper lung nodules showed hyperintensity. In addition, CT and MR findings of pulmonary cryptococcal infection, pulmonary IMT and lung cancer were preliminarily compared in this study (Figs. 4 and 5). IMT showed shallow lobulation, the boundary of cryptococcal infection was blurred, and lung cancer showed deep lobulation. IMT showed mild to moderate uneven delayed enhancement, cryptococcal infection showed obvious uniform enhancement, and lung cancer showed obvious uneven enhancement. Magnetic resonance imaging of the 3 lesions showed that the nodules showed the same T1 signal and slightly longer T2 signal, and the DWI of lung cancer showed high signal and significantly reduced ADC signal, which was consistent with the report of Shen et al[19] IMT and DWI of cryptococcal infection showed high signal intensity, and there was no significant difference between the signal intensity and lung cancer. ADC signal intensity of lung cancer was the lowest, while that of IMT was the highest. ADC signal intensity of pulmonary cryptococcal infection was higher than that of lung cancer and slightly lower than that of IMT. However, ADC signal intensity of IMT and cryptococcal infection was similar, so it was still difficult to distinguish them. In conclusion, the combined DWI and ADC imaging technology has certain value in the diagnosis and differential diagnosis of IMT and lung malignant tumors, and the differential diagnosis value of IMT and benign lung lesions needs to be further explored. The thoracic surgeon combined with the good suggestions given by the imaging, comprehensively analyzed the results and sought the opinions of the related experts in pathology and anesthesiology, designed the precise surgical plan and completed the operation with the surgical method of lung tumors with nonmalignant tendency.
9. Conclusion
After pulmonary nodules appear in children or young patients, chest CT examination combined with DWI and ADC imaging technology has high clinical significance for the diagnosis of IMT, which has reference value for doctors to choose conservative treatment and surgical treatment, and is helpful for the long-term health of patients.
Author contributions
Conceptualization: Lv Sun.
Investigation: Yuhang Zhu, Cheng Chen, Jiajia Huang.
Project administration: Lv Sun.
Resources: Cheng Chen, Jiajia Huang, Bangguo Li.
Supervision: Bangguo Li.
Visualization: Yuhang Zhu.
Writing – original draft: Lv Sun.
Writing – review & editing: Lv Sun.
Abbreviations:
- ADC
- apparent diffusion coefficient
- CT
- computed tomography
- DWI
- diffusion-weighted imaging
- IMT
- inflammatory myofibroblastic tumor
The datasets generated during and/or analyzed during the current study are not publicly available, but are available from the corresponding author on reasonable request.
Written informed consent was obtained from the patient for publication of this case report and accompanying images.
The authors have no funding and conflicts of interest to disclose.
How to cite this article: Sun L, Zhu Y, Chen C, Huang J, Li B. Accurate diagnosis of pulmonary inflammatory myofibroblastic tumor by imaging technology before operation: A case report. Medicine 2023;102:35(e34798).
Contributor Information
Yuhang Zhu, Email: zhuyuhang_zmc@sina.com.
Cheng Chen, Email: 18685266729@163.com.
Jiajia Huang, Email: huangjiaabcd@qq.com.
Bangguo Li, Email: lbg2015@163.com.
References
- [1].Mazzone PJ, Gould MK, Arenberg DA, et al. Management of lung nodules and lung cancer screening during the COVID-19 pandemic: CHEST expert panel report. Chest. 2020;158:406–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Mahajan P, Casanova M, Ferrari A, et al. Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges. Curr Probl Cancer. 2021;45:100768. [DOI] [PubMed] [Google Scholar]
- [3].Janik JS, Janik JP, Lovell MA, et al. Recurrent inflammatory pseudotumors in children. J Pediatr Surg. 2003;38:1491–5. [DOI] [PubMed] [Google Scholar]
- [4].Reinke DK. Meaningful engagement of the patient in rare cancer research: sarcoma as an exemplar. Curr Probl Cancer. 2021;45:100772. [DOI] [PubMed] [Google Scholar]
- [5].Karnak I, Senocak ME, Ciftci AO, et al. Inflammatory myofibroblastic tumor in children: diagnosis and treatment. J Pediatr Surg. 2001;36:908–12. [DOI] [PubMed] [Google Scholar]
- [6].Ekinci GH, Haciomeroglu O, Sen AC, et al. Inflammatory myofibroblastic tumor of the lung. J Coll Physicians Surg Pak. 2016;26:331–3. [PubMed] [Google Scholar]
- [7].Yang F, Zhang W, Han C, et al. A case of pulmonary inflammatory myofibroblastic tumor treated with bronchoscopic therapy plus lobectomy. J Cardiothorac Surg. 2021;16:144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Ikeda T, Nakano J, Kushida Y, et al. Multiple pulmonary inflammatory myofibroblastic tumor. Kyobu Geka. 2019;72:367–70. [PubMed] [Google Scholar]
- [9].Braham Y, Migaou A, Njima M, et al. Inflammatory myofibroblastic tumor of the lung: a rare entity. Respir Med Case Rep. 2020;31:101287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Na Y, Park S. Inflammatory myofibroblastic tumor of the pleura with adjacent chest wall invasion and metastasis to the kidney: a case report. J Med Case Rep. 2018;12:253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Ufuk F, Herek D, Karabulut N. Inflammatory myofibroblastic tumor of the lung: unusual imaging findings of three cases. Pol J Radiol. 2015;80:479–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Li H, He Y, Wang B, et al. Rare cases of pulmonary inflammatory myofibroblastic tumors in adult male patients: a case report. Transl Cancer Res. 2021;10:4274–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Naime S, Bandarkar A, Nino G, et al. Pulmonary inflammatory myofibroblastic tumour misdiagnosed as a round pneumonia. BMJ Case Rep. 2018;2018:bcr2017224091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Santos MK, Elias J, Jr, Mauad FM, et al. Magnetic resonance imaging of the chest: current and new applications, with an emphasis on pulmonology. J Bras Pneumol. 2011;37:242–58. [DOI] [PubMed] [Google Scholar]
- [15].Baba S, Isoda T, Maruoka Y, et al. Diagnostic and prognostic value of pretreatment SUV in 18F-FDG/PET in breast cancer: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging. J Nucl Med. 2014;55:736–42. [DOI] [PubMed] [Google Scholar]
- [16].Thörmer G, Otto J, Reiss-Zimmermann M, et al. Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values. Eur Radiol. 2012;22:1820–8. [DOI] [PubMed] [Google Scholar]
- [17].Kuang F, Ren J, Zhong Q, et al. The value of apparent diffusion coefficient in the assessment of cervical cancer. Eur Radiol. 2013;23:1050–8. [DOI] [PubMed] [Google Scholar]
- [18].Tondo F, Saponaro A, Stecco A, et al. Role of diffusion-weighted imaging in the differential diagnosis of benign and malignant lesions of the chest-mediastinum. Radiol Med. 2011;116:720–33. [DOI] [PubMed] [Google Scholar]
- [19].Shen G, Jia Z, Deng H. Apparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis. Eur Radiol. 2016;26:556–66. [DOI] [PubMed] [Google Scholar]